Zur Rose Group AG announced that the person responsible for the Germany segment (Head Germany) and CEO of DocMorris, Olaf Heinrich, has decided to leave the Zur Rose Group for personal reasons. He will be succeeded by Walter Hess, head of the Switzerland segment (Head Switzerland). Emanuel Lorini, head of the physicians business, will be the new responsible for the Switzerland business. Olaf Heinrich has decided to leave the Zur Rose Group for personal reasons. He has been CEO of DocMorris since 2009 and has been responsible for the overall management of the German business since 2017. Walter Hess, who is responsible for the Switzerland segment, will take over the management of the Germany segment and the position as CEO of DocMorris with immediate effect. As a member of the Group Management, Walter Hess is very familiar with the online business, the strategic projects, but also with the opportunities and challenges presented in Germany. In addition, he himself headed the German subsidiary Zur Rose Pharma GmbH in Halle (Saale) for several years and previously worked as an external consultant for the Zur Rose Group in Germany. Emanuel Lorini, head of the physicians business (B2B) since 2011 and member of the Management Board of Zur Rose Suisse AG, will assume the position of Head of the Switzerland segment.